A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2001
12/19/2001	EP1163356A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
12/19/2001	EP1163337A2 Vascular adhesion molecules and modulation of their function
12/19/2001	EP1163336A2 Vertebrate protein slit, dna sequence encoding it and uses thereof
12/19/2001	EP1163335A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
12/19/2001	EP1163334A1 Polynucleotide and deduced amino acid sequences from stromal cells
12/19/2001	EP1163331A1 50 human secreted proteins
12/19/2001	EP1163270A1 Dihydroouabain-like factor and diagnostic and therapeutic compositions and methods
12/19/2001	EP1163267A1 47 human secreted proteins
12/19/2001	EP1163262A1 Phenylalanine derivatives
12/19/2001	EP1163255A1 50 human secreted proteins
12/19/2001	EP1163239A1 Modified amino-acid amides as cgrp antagonists
12/19/2001	EP1163237A1 Amide derivatives
12/19/2001	EP1163236A1 Aromatic heterocyclic compounds as anti-inflammatory agents
12/19/2001	EP1163233A1 Fused 1,4-thiazine-2-carbonitrile derivatives, their preparation and use
12/19/2001	EP1163226A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
12/19/2001	EP1163225A1 Compounds and methods for modulation of estrogen receptors
12/19/2001	EP1163221A1 Sulfonamide derivatives as 5ht7 receptor antagonists
12/19/2001	EP1163220A1 Tricyclic indole-2-carboxylic acid compound used as nmda receptor antagonist
12/19/2001	EP1163214A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3
12/19/2001	EP1163213A1 Hydroxamic and carboxylic acid derivatives
12/19/2001	EP1163212A1 Amide derivatives
12/19/2001	EP1163208A2 Caspase inhibitors and uses thereof
12/19/2001	EP1163204A1 Lipoxin compounds and their use
12/19/2001	EP1163203A1 Crystalline hydrated dihydroxy open-acid simvastatin calcium salt
12/19/2001	EP1162997A2 Staphylococcus antigen and vaccine
12/19/2001	EP1162990A1 Treatment with small peptides to effect antifibrotic activity
12/19/2001	EP1162987A1 Pharmaceutical composition for medical and veterinary use for regenerating intestinal flora in diarrhoea or dyspeptic syndrome
12/19/2001	EP1162984A2 Use of cross linked polysaccharides for the inhibition of angiogenesis
12/19/2001	EP1162981A1 Treatment of accidental extravasation of anthracyclines
12/19/2001	EP1162980A2 Use of pyridoxine compounds for the treatment of cardiovascular and related pathologies
12/19/2001	EP1162976A2 Regulation of phospholipase d activity
12/19/2001	EP1162970A2 Anti-inflammatory uses of manzamines
12/19/2001	EP1162968A1 Use of epigallocatechin-gallate for inhibiting angiogenesis
12/19/2001	EP1162964A1 Treatment of pulmonary hypertension
12/19/2001	EP1162957A1 Method for improving the stability of stored and/or used light-sensitive therapeutic systems or components thereof
12/19/2001	EP1094816A4 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/19/2001	EP0813520B1 Arylsulfonylamino hydroxamic acid derivatives
12/19/2001	EP0751785B2 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof
12/19/2001	EP0699068B1 Reduction of liposome-induced adverse physiological reactions
12/19/2001	CN1327444A Alpha 1 beta-adrenergic receptor antagonists
12/19/2001	CN1327389A Coupling factor 6 inhibitor and potentiator and use thereof
12/19/2001	CN1327383A Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/19/2001	CN1326744A New use of polyunsaturated lecithin
12/19/2001	CN1326734A Thrombolytic injection for curing cerebral infarction or cerebral thrombus
12/19/2001	CN1076356C Protein having TPO activity
12/19/2001	CN1076353C Alkyl boronic acid derivatives, process for their preparation and pharmaceutical compositions containing them
12/19/2001	CN1076348C 3-bustituted oxindole derivatives as patassium path regulating agent
12/19/2001	CN1076200C Medicine for curing cardiovascular diseases
12/19/2001	CN1076172C Health tea and its preparing method
12/18/2001	US6331640 Diaminopropionic acid derivatives
12/18/2001	US6331637 N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
12/18/2001	US6331623 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action
12/18/2001	US6331556 Benzofuran-4-carboxylic acid amide derivatives used as phosphodiesterase iv or tumor necrosis factor inhibitors
12/18/2001	US6331553 Inhibitors of nitric oxide synthase; treating cerebrovascular diseases
12/18/2001	US6331552 Therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorders
12/18/2001	US6331549 Treatment of urinary stress incontinence, venous insufficiency, venous ulcers, migraine or gastrointestinal disorders
12/18/2001	US6331546 Use of 2-amino-3,4-dihydroquinazolines for the production of a medicament for the treatment or prophylaxis of illnesses caused by ischemic conditions
12/18/2001	US6331544 Treating positive and negative symptoms of schizophrenia and other psychoses
12/18/2001	US6331527 Promoter smooth muscle cell expression
12/18/2001	US6331423 Nucleotide sequences coding polypeptide for use as human therapeutic agents that modulate kinase activity
12/18/2001	US6331410 Polynucleotides encoding a novel pyrR homolog
12/18/2001	US6331309 Hydrogel compositions for the controlled release administration of growth factors
12/18/2001	US6331301 Isolated dna sequences which encodes amino acid sequence in protein;
12/18/2001	CA2221448C Antisense oligonucleotide modulation of raf gene expression
12/18/2001	CA2178161C Indole derivatives
12/18/2001	CA2160725C Process for the preparation of a tetrazole derivative in two crystalline forms and novel crystalline form of said derivative
12/18/2001	CA2082923C Sulfonyl compounds
12/18/2001	CA2031897C Carbamoyl derivatives
12/13/2001	WO2001094952A2 Methods and compositions for modulating oxidized ldl transport
12/13/2001	WO2001094951A2 Inhibitors of c-reactive protein induced inflammation
12/13/2001	WO2001094636A2 Compositions, kits, and methods for identification and modulation of type i diabetes
12/13/2001	WO2001094616A1 Protein markers for pharmaceuticals and related toxicity
12/13/2001	WO2001094613A2 Methods and compounds for influencing beta3 integrin-dependent intracellular processes
12/13/2001	WO2001094612A2 Method for identifying medically valuable active substances
12/13/2001	WO2001094582A1 Novel g protein-coupled receptor protein and dna thereof
12/13/2001	WO2001094555A1 Method for obtaining characterised muscle-derived cell populations and uses
12/13/2001	WO2001094547A2 Molecular delivery vehicle for delivery of selected compounds to targets
12/13/2001	WO2001094420A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
12/13/2001	WO2001094415A2 Nuclear hormone receptor
12/13/2001	WO2001094414A2 THE HUMAN VOLTAGE GATED SODIUM CHANNEL β-1A SUBUNIT AND METHODS OF USE
12/13/2001	WO2001094413A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
12/13/2001	WO2001094391A2 Intracellular signaling proteins
12/13/2001	WO2001094368A1 2-aminocarbonyl-9h-purine derivatives
12/13/2001	WO2001094351A1 Caspase inhibitors and uses thereof
12/13/2001	WO2001094350A1 6-phenylpyrrolopyrimidinedione derivatives
12/13/2001	WO2001094347A1 Tetracyclic diketopiperazine compounds as pdev inhibitors
12/13/2001	WO2001094346A1 1,3,8-TRIAZA-SPIRO'4,5&excl;DECAN-4-ONE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS
12/13/2001	WO2001094345A2 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
12/13/2001	WO2001094333A2 Process for the preparation of benzoyl substituted bicyclic compounds and chiral benzopyran derivatives
12/13/2001	WO2001094326A1 Novel thiazolidinedione derivatives and use thereof as drugs
12/13/2001	WO2001094325A1 2-aminothiazoline derivatives and their use as no-synthase inhibitors
12/13/2001	WO2001094319A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
12/13/2001	WO2001094312A2 Indolinone derivatives as protein kinase/phosphatase inhibitors
12/13/2001	WO2001094293A2 Benzamide ligands for the thyroid receptor
12/13/2001	WO2001094279A2 Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls
12/13/2001	WO2001093911A2 Macromolecular drug complexes and compositions containing the same
12/13/2001	WO2001093900A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
12/13/2001	WO2001093892A1 Methods and compositions for inhibiting immunoglobulin-mediated__reperfusion injury
12/13/2001	WO2001093885A1 Therapeutic agents - ii
12/13/2001	WO2001093884A1 Therapeutic agents - i

1 ... 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 ... 1595